Advanced Endoscopic Resections for Rectal Neoplasms
- Sponsor
- Jagiellonian University
- Study ID
- NCT07410767
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Rectal Adenocarcinoma
- Rectal Adenoma
- Rectal Cancer
- Rectal Neuroendocrine Neoplasm
- Recurrent Rectal Adenocarcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Endoscopic submucosal dissection — PROCEDUREEndoscopic submucosal dissection is an advanced endoscopic technique used to remove rectal tumors in one piece through the endoscope. A circumferential incision is then made in the mucosa, followed by careful dissection within the submucosal layer until the lesion is completely removed. This technique enables precise pathological assessment of tumor margins and depth of invasion and is typically used for lesions suspected to have superficial submucosal invasion without clear evidence of lymph node involvement. The procedure is performed using standard therapeutic endoscopic equipment and electrosurgical devices.
- Endoscopic intramuscular dissection — PROCEDUREEndoscopic intermuscular dissection is an advanced endoscopic resection technique designed for rectal tumors with suspected deeper submucosal invasion. Following mucosal incision, the dissection is intentionally performed in the plane between the inner circular and outer longitudinal muscle layers of the rectal wall. This allows deeper en bloc tumor removal compared with conventional endoscopic submucosal dissection. The goal of this technique is to achieve complete resection while potentially avoiding radical surgery in selected patients. The procedure is performed endoscopically using specialized dissection knives and electrosurgical systems and requires advanced operator expertise.
Study Details
This study evaluates how advanced endoscopic resection techniques affect treatment outcomes in adults with rectal cancer. Rectal cancer has traditionally been treated with standard abdominal surgery. Newer endoscopic techniques allow removal of selected early tumors and may reduce treatment-related complications. However, their effectiveness and safety in tumors with deeper invasion are not yet fully established. This multicenter retrospective observational study uses existing medical records from adults who underwent endoscopic or surgical resection of rectal tumors between 2015 and 2025. Researchers will analyze anonymized information on procedures performed and treatment outcomes to assess the safety and effectiveness of advanced endoscopic approaches. The results of this study may help guide treatment selection and improve care for people with rectal cancer.
Key Dates
- First listed
- Feb 13, 2026
- Start date
- Mar 1, 2026
- Status verified
- Feb 2026
- Primary completion
- Apr 30, 2026
- Completion
- Apr 30, 2026
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: ESDPatients who underwent endoscopic submucosal dissection for rectal neoplasm
- Arm: EIDPatients who underwent endoscopic intermuscular dissection for rectal neoplasm
Primary Outcome Measure
Major intraprocedural bleeding rate [ Time Frame: During the procedure ]
Central Contacts
- Zofia Orzeszko, MD+123797145
Find similar trials
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal CancerRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 PatientsPHASE1/PHASE2 · Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal CancerPHASE1/PHASE2 · Recruiting · Washington University School of Medicine · Boston, Massachusetts